Navigation Links
Unmask Blood RNA for Gene Expression Profiling

GLOBINclear-Human Globin mRNA Removal Kit
Depletes alpha and beta globin mRNA from blood total RNA with a simple magnetic bead procedure (no enzymatic treatments)

Increases sensitivity of gene detection in microarray profiling experiments

Integrates easily with the RiboPure-Blood Kit and MessageAmp II aRNA Amplification System for expression profiling


Total RNA from Whole Blood

The easy accessibility of blood makes it the most common tissue studied in clinical research, but blood consists of a heterogeneous population of cells, including erythrocytes, granulocytes, and other peripheral blood mononuclear cells. One obstacle for expression profiling RNA from whole blood is the relatively high content of globin messenger RNA (mRNA) from immature red blood cells. In fact, up to 70% of the mRNA mass is from globin transcripts.


Globin Transcript Removal

Ambion's GLOBINclear-Human Kit is designed to rapidly deplete alpha and beta globin mRNA from total RNA preparations derived from human whole blood. The kit employs a novel hybridization capture technology (see "Simple, Effective Globin mRNA Reduction Protocol" at right) that uses the power of biotin/streptavidin binding and the specificity of nucleic acid hybridization to effectively remove 9099.5% globin transcripts from blood total RNA (Figure 1).

Figure 1. Electropherogram of Amplified RNA from Human Whole Blood. Total RNA was isolated from whole blood using the RiboPure-Blood Kit (Ambion). Total RNA (5 g) was treated with the GLOBINclear Kit (Ambion). MessageAmp II aRNA Amplification Kit (Ambion) was used to linearly amplify 2 g total RNA or RNA enriched by the GLOBINclear Kit. The resulting aRNA was resolved on an Agilent 2100 bioanalyzer RNA LabChip assay to monitor quality and quantity. Note the complete removal of the abundant "globin spike" in the GLOBINclear-treated RNA that is present in the whole blood aRNA sample.


Successful Gene Expression Profiling

To further test the specificity of globin mRNA reduction, synthetic globin transcripts were added to HeLa cell RNA, and samples were processed or left unprocessed with the GLOBINclear Kit (Figure 2). In microarray analyses, the GLOBINclear protocol did not alter the profiles from HeLa RNA preparations. However, the GLOBINclear process was able to rescue the decreased gene detection observed with RNA samples containing high levels of exogenous globin transcripts.

Figure 2. Percent Present Calls for Samples Treated or Untreated with GLOBINclear-Human Globin mRNA Removal Kit. In a control experiment, the GLOBINclear Kit (Ambion) did not significantly alter the Percent Present Call results from RNA samples derived from a cultured cell line (HeLa cells) that does not express high levels of globin (left two bars). In contrast, the GLOBINclear Kit rescued the decreased gene detection observed when exogenous globin transcripts were spiked into the HeLa RNA samples. Total RNA was isolated from human blood samples with the RiboPure-Blood Kit (Ambion). While half of the samples were processed with the GLOBINclear Kit before RNA amplification (MessageAmp II Kit, Ambion), half of the total RNA preparations were used directly for RNA amplification. Labeled aRNA was hybridized to an Affymetrix GeneChip Human Genome Focus Array. Percent Present Calls were ~10% (~1000 genes) lower for samples that were not treated with the GLOBINclear Kit.


Globin mRNA levels can vary among donors, which can unpredictably affect RNA amplification and array results and therefore, confound interpretations that are made when comparing different samples. With the removal of globin transcripts, the enriched RNA samples become superior templates for RNA expression profiling because the presence of globin mRNA is no longer a factor in decreasing the sensitivity of gene detection on microarrays (Figure 2).


GLOBINclear-Human Globin mRNA Removal Kit

The GLOBINclear protocol is compatible with total RNA obtained from any high quality whole blood RNA isolation procedure. This kit was developed to reduce or eliminate the negative effects of globin mRNA on high density oligonucleotide expression profiling, and the resulting enriched RNA is compatible with the RiboPure-Blood Kit and the MessageAmp II aRNA Amplification System. The GLOBINclear Kit contains enough reagents to deplete globin mRNA from 20 samples of total RNA derived from human whole blo od (110 g per sample).

The GLOBINclear Protocol .


Scientific Contributors
Penn Whitley, Sharmili Moturi, Robert Setterquist * Ambion, Inc.


back to top


Ordering Information
Cat# Product Name Size 1751 MessageAmp II aRNA Amplification Kit 20 rxns 1753 Amino Allyl MessageAmp II aRNA Amplification Kit 20 rxns 1928 RiboPure-Blood Kit 40 purifications 1980 GLOBINclearHuman 20 rxns 10055 6 Tube Magnetic Stand 1 each
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood
2. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
3. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
4. EppendorfPerfect gDNA Blood Mini Kit
5. Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit by Varying the Final Elution Volume
6. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
7. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
8. Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit by Varying the Final Elution Volume
9. EppendorfPerfect gDNA Blood Mini Kit
10. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
11. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... , February 17, 2017 ... Market by Product (Consumables, Service), Type (Safety, Efficacy, ... Development, Drug Discovery and Development, Disease-Risk) - Global ... is projected to reach USD 53.34 Billion by ... at a CAGR of 13.8% during the forecast ...
(Date:2/17/2017)... 2017  If only one in every hundred ... resistance to chemotherapy, thousands of cancer cells would ... on finding these mutations in ever-smaller subpopulations of ... DNA in blood — to guide treatment decisions ... Unfortunately, however, detecting these genetic anomalies may be ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... ... February 16, 2017 , ... Avomeen & MichBio will be hosting a ... held at Avomeen Analytical Services (4840 Venture Dr., Ann Arbor, Michigan 48108). BioMixers ... an opportunity to interact with peers, make new connections and talk bio biz. , ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
(Date:1/12/2017)...  New research undertaken by Fit Small Business ... participants were simply asked which office technology had they not ... standard issue.  Insights on what will be key ... futurists and industry leaders including Penelope Trunk , ... Some of these findings included; ...
Breaking Biology News(10 mins):